No Data
No Data
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Is Going Strong But Fundamentals Appear To Be Mixed : Is There A Clear Direction For The Stock?
Analysts Offer Insights on Healthcare Companies: Merus (MRUS), Supernus Pharmaceuticals (SUPN) and Skye Bioscience (SKYE)
Piper Sandler Sticks to Their Hold Rating for Supernus Pharmaceuticals (SUPN)
Screening For Black Friday Bargains In The Stock Market
Supernus to Participate in the 36th Annual Piper Sandler Healthcare Conference
Numerous Supernus Pharmaceuticals Insiders Sold Stock: Not A Positive Omen
No Data